FindTrial
Sign In

RET rearrangement testing of Chinese NSCLCs: a retrospective non-interventional multi-center study

RET rearrangement testing of Chinese NSCLCs: a retrospective non-interventional multi-center study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047992
Enrollment
Unknown
Registered
2021-06-28
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

case group:Nil

Sponsors

National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed as non-small cell lung cancer; 2.Patients underwent RET testing according to electronic medical records.

Exclusion criteria

Exclusion criteria: 1.RET testing by a third party outside the hospital.

Design outcomes

Primary

MeasureTime frame
RET positive rate;—

Secondary

MeasureTime frame
RET testing methods / platform;RET testing cost;—

Countries

China

Contacts

Public ContactYing Jianming

National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

jmying@cicams.ac.cn+86 13466396748

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026